26.02.2019 • NewsAcetoElaine Burridge

Aceto to Sell Chemicals Assets to New Mountain Capital

Aceto to Sell Chemicals Assets to New Mountain Capital (c) Gunnar...
Aceto to Sell Chemicals Assets to New Mountain Capital (c) Gunnar Pippel/Shutterstock

US-based Aceto Corp. is selling its chemicals assets to investment firm New Mountain Capital for $338 million under a “stalking-horse” agreement.

Aceto and its US subsidiaries filed for voluntary bankruptcy under Chapter 11 in a New Jersey court on Feb. 20. The company is focused on the marketing, sale and distribution of human health products (finished dosage form generics and nutraceutical products), pharmaceutical ingredients and performance chemicals (specialties and crop protection products).

The company operates in nine countries, including Germany, the Netherlands, France, China, Singapore, India, the Philippines and the US.

Although not included in the Chapter 11 filings, Aceto’s foreign chemicals subsidiaries will be included in the sale. Aceto also intends to enter into a stalking horse agreement for its New Jersey-based subsidiary, Rising Pharmaceuticals. Both transactions are expected to complete before Aceto’s fiscal year ends on Jun. 30, 2019.

William Kennally III, Aceto’s CEO, said the board has been evaluating strategic alternatives to address its debt burden for several months and has finally decided to pursue a court-supervised sale. He commented: “This decision provides stability and deep capital resources to the company and, importantly, ensures the continuity of customer, partner and supplier relationships critical to the company’s businesses operations and success.”

A syndicate of lenders led by Wells Fargo Bank has committed to provide funds of $60 million to finance Aceto’s working capital needs and support payments to vendors and suppliers while the transactions proceed to completion.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.